Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults

Brain and Development

Volumn 32, Issue 2, 2010, Pages 82-89

  Kohlschütter, Alfried ^a   Bley, Annette ^a   Brockmann, Knut ^b   Gärtner, Jutta ^b   Krägeloh Mann, Ingeborg ^c   Rolfs, Arndt ^d   Schöls, Ludger ^e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Diagnosis; Genetic brain disease; Inborn error of metabolism; Neuroradiology

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; ALPHA GALACTOSIDASE; ALPHA LEVO FUCOSIDASE; ASPARTOACYLASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE A; CEREBROSIDE SULFATASE; CHOLESTANETRIOL 26 MONOOXYGENASE; GALACTOSYLCERAMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOSAMINOGLYCAN; INTERFERON; N ACETYLASPARTIC ACID; PROTEOLIPID PROTEIN; SIALIC ACID; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; AICARDI GOUTIERES SYNDROME; ALEXANDER DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; BIOTINIDASE DEFICIENCY; CADASIL; CANAVAN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL FEATURE; COCKAYNE SYNDROME; CONGENITAL DISORDER OF GLYCOSYLATION; FABRY DISEASE; FUCOSIDOSIS; GLOBOID CELL LEUKODYSTROPHY; GM1 GANGLIOSIDOSIS; HUMAN; LEUKODYSTROPHY; LEUKOENCEPHALOPATHY; METACHROMATIC LEUKODYSTROPHY; MUCOLIPIDOSIS; MUCOPOLYSACCHARIDOSIS; MULTIPLE SULFATASE DEFICIENCY; NERVE CONDUCTION; NEUROAXONAL DYSTROPHY; NIEMANN PICK DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; PELIZAEUS MERZBACHER DISEASE; REVIEW; SIALIC ACID STORAGE DISEASE; SJOEGREN LARSSON SYNDROME; TAY SACHS DISEASE; TRICHOTHIODYSTROPHY; WHITE MATTER; X CHROMOSOME RECESSIVE INHERITANCE; ZELLWEGER SYNDROME;

EID: 73749088374     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2009.03.014     Document Type: Review

References (100)

1. Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2009, http://www.ncbi.nlm.nih.gov/omim.
2. Van der Knaap MS, Valk J. Magnetic resonance of myelination and myelin disorders. 3rd ed. Berlin: Springer; 2005 (1084p).
3. OMMBID - The Online Metabolic and Molecular Bases of Inherited Disease. The McGraw-Hill Companies, Inc., 2009, http://www.ommbid.com.
4. von Figura K., Gieselmann V., and Jaeken J. Metachromatic leukodystrophy. In: Scriver C.R., Beaudet A.L., Valle D., et al. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 3695-3724
5. Deconinck N., Messaaoui A., Ziereisen F., Kadhim H., Sznajer Y., Pelc K., et al. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin B deficiency. Eur J Paediatr Neurol 12 (2008) 46-50
6. Dierks T., Schmidt B., Borissenko L.V., Peng J., Preusser A., Mariappan M., et al. Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell 113 (2003) 435-444
7. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol 18 (2003) 595-603
8. Spiegel R., Bach G., Sury V., Mengistu G., Meidan B., Shalev S., et al. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Mol Genet Metab 84 (2005) 160-166
9. Sonninen P., Autti T., Varho T., Hamalainen M., and Raininko R. Brain involvement in Salla disease. AJNR Am J Neuroradiol 20 (1999) 433-443
10. Varho T., Jaaskelainen S., Tolonen U., Sonninen P., Vainionpaa L., Aula P., et al. Central and peripheral nervous system dysfunction in the clinical variation of Salla disease. Neurology 55 (2000) 99-104
11. Prietsch V., Arnold S., Kraegeloh-Mann I., Kuehr J., and Santer R. Severe hypomyelination as the leading neuroradiological sign in a patient with fucosidosis. Neuropediatrics 39 (2008) 51-54
12. van der Voorn J.P., Kamphorst W., van der Knaap M.S., and Powers J.M. The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction. Acta Neuropathol (Berl) 107 (2004) 539-545
13. Di Rocco M., Rossi A., Parenti G., Allegri A.E., Filocamo M., Pessagno A., et al. Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders. Neuropediatrics 36 (2005) 265-269
14. Grodd W., and Krägeloh-Mann I. Stoffwechselstörungen im Kindesalter. In: Jansen O., and Stephani U. (Eds). Fehlbildungen und frühkindliche Schädigungen des ZNS. Referenz-Reihe Neurologie (2007), Thieme, Stuttgart 114-181
15. Mugikura S., Takahashi S., Higano S., Kurihara N., Kon K., and Sakamoto K. MR findings in Tay-Sachs disease. J Comput Assist Tomogr 20 (1996) 551-555
16. Fellgiebel A., Keller I., Marin D., Muller M.J., Schermuly I., Yakushev I., et al. Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 72 (2009) 63-68
17. Trouard T.P., Heidenreich R.A., Seeger J.F., and Erickson R.P. Diffusion tensor imaging in Niemann-Pick Type C disease. Pediatr Neurol 33 (2005) 325-330
18. Wilken B., Dechent P., Brockmann K., Finsterbusch J., Baumann M., Ebell W., et al. Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation. Neuropediatrics 34 (2003) 237-246
19. Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In: Valle D, Beaudet AL, Vogelstein B et al., editors. The online metabolic and molecular bases of inherited disease. 2001. p. 1-98.
20. Moser H.W., Mahmood A., and Raymond G.V. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3 (2007) 140-151
21. Barth P.G., Majoie C.B., Gootjes J., Wanders R.J., Waterham H.R., van der Knaap M.S., et al. Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival. Neurology 62 (2004) 439-444
22. Krause C., Rosewich H., Thanos M., and Gartner J. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients. Hum Mutat 27 (2006) 1157
23. Moser A.B., Rasmussen M., Naidu S., Watkins P.A., McGuinness M., Hajra A.K., et al. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 127 (1995) 13-22
24. Kurian M.A., Ryan S., Besley G.T., Wanders R.J., and King M.D. Straight-chain acyl-CoA oxidase deficiency presenting with dysmorphia, neurodevelopmental autistic-type regression and a selective pattern of leukodystrophy. J Inherit Metab Dis 27 (2004) 105-108
25. Janson C.G., McPhee S.W., Francis J., Shera D., Assadi M., Freese A., et al. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Neuropediatrics 37 (2006) 209-221
26. Brockmann K., Dechent P., Meins M., Haupt M., Sperner J., Stephani U., et al. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol 250 (2003) 300-306
27. Neumaier Probst E., Hagel C., Weisz V., Nagel S., Wittkugel O., Zeumer H., et al. Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann Neurol 53 (2003) 118-120
28. van der Knaap M.S., Naidu S., Breiter S.N., Blaser S., Stroink H., Springer S., et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 22 (2001) 541-552
29. Schuelke M., Smeitink J., Mariman E., Loeffen J., Plecko B., Trijbels F., et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21 (1999) 260-261
30. van der Knaap M.S., Ramesh V., Schiffmann R., Blaser S., Kyllerman M., Gholkar A., et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology 66 (2006) 494-498
31. Springer S., Erlewein R., Naegele T., Becker I., Auer D., Grodd W., et al. Alexander disease - classification revisited and isolation of a neonatal form. Neuropediatrics 31 (2000) 86-92
32. Riecker A., Nagele T., Henneke M., and Schols L. Late onset vanishing white matter disease. J Neurol 254 (2007) 544-545
33. van der Knaap M.S., Pronk J.C., and Scheper G.C. Vanishing white matter disease. Lancet Neurol 5 (2006) 413-423
34. Eldridge R., Anayiotos C.P., Schlesinger S., Cowen D., Bever C., Patronas N., et al. Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. N Engl J Med 311 (1984) 948-953
35. Labauge P., Fogli A., Castelnovo G., Le Bayon A., Horzinski L., Nicoli F., et al. Dominant form of vanishing white matter-like leukoencephalopathy. Ann Neurol 58 (2005) 634-639
36. Padiath Q.S., Saigoh K., Schiffmann R., Asahara H., Yamada T., Koeppen A., et al. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38 (2006) 1114-1123
37. Barkhof F., Verrips A., Wesseling P., van Der Knaap M.S., van Engelen B.G., Gabreels F.J., et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217 (2000) 869-876
38. Lorincz M.T., Rainier S., Thomas D., and Fink J.K. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol 62 (2005) 1459-1463
39. Gallus G.N., Dotti M.T., and Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 27 (2006) 143-149
40. Inoue K. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6 (2005) 1-16
41. Hanefeld F.A., Brockmann K., Pouwels P.J., Wilken B., Frahm J., and Dechent P. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination. Neurology 65 (2005) 701-706
42. Wang P.J., Young C., Liu H.M., Chang Y.C., and Shen Y.Z. Neurophysiologic studies and MRI in Pelizaeus-Merzbacher disease: comparison of classic and connatal forms. Pediatr Neurol 12 (1995) 47-53
43. Uhlenberg B., Schuelke M., Ruschendorf F., Ruf N., Kaindl A.M., Henneke M., et al. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 75 (2004) 251-260
44. Wolf N.I., Cundall M., Rutland P., Rosser E., Surtees R., Benton S., et al. Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics 8 (2007) 39-44
45. Wolf N.I., Willemsen M.A., Engelke U.F., van der Knaap M.S., Pouwels P.J., Harting I., et al. Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology 62 (2004) 1503-1508
46. de Koning T.J., Jaeken J., Pineda M., Van Maldergem L., Poll-The B.T., and van der Knaap M.S. Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics 31 (2000) 287-292
47. van der Knaap M.S., Naidu S., Pouwels P.J., Bonavita S., van Coster R., Lagae L., et al. New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum. AJNR Am J Neuroradiol 23 (2002) 1466-1474
48. Wakusawa K., Haginoya K., Kitamura T., Togashi N., Ishitobi M., Yokoyama H., et al. Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum. Tohoku J Exp Med 209 (2006) 163-167
49. van der Knaap M.S., Linnankivi T., Paetau A., Feigenbaum A., Wakusawa K., Haginoya K., et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology 69 (2007) 166-171
50. Biancheri R., Zara F., Bruno C., Rossi A., Bordo L., Gazzerro E., et al. Phenotypic characterization of hypomyelination and congenital cataract. Ann Neurol 62 (2007) 121-127
51. Lancaster J.L., Cody J.D., Andrews T., Hardies L.J., Hale D.E., and Fox P.T. Myelination in children with partial deletions of chromosome 18q. AJNR Am J Neuroradiol 26 (2005) 447-454
52. Linnankivi T., Tienari P., Somer M., Kahkonen M., Lonnqvist T., Valanne L., et al. 18q deletions: clinical, molecular, and brain MRI findings of 14 individuals. Am J Med Genet A 140 (2006) 331-339
53. Wolf N.I., Harting I., Boltshauser E., Wiegand G., Koch M.J., Schmitt-Mechelke T., et al. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology 64 (2005) 1461-1464
54. Wolf N.I., Harting I., Innes A.M., Patzer S., Zeitler P., Schneider A., et al. Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy. Neuropediatrics 38 (2007) 64-70
55. Sijens P.E., Rodiger L.A., Meiners L.C., and Lunsing R.J. 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency. J Clin Endocrinol Metab 93 (2008) 1854-1859
56. van der Knaap M.S., Barth P.G., Stroink H., van Nieuwenhuizen O., Arts W.F., Hoogenraad F., et al. Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 37 (1995) 324-334
57. Gorospe J.R., Singhal B.S., Kainu T., Wu F., Stephan D., Trent J., et al. Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. Neurology 62 (2004) 878-882
58. Itoh N., Maeda M., Naito Y., Narita Y., and Kuzuhara S. An adult case of megalencephalic leukoencephalopathy with subcortical cysts with S93L mutation in MLC1 gene: a case report and diffusion MRI. Eur Neurol 56 (2006) 243-245
59. Crow Y.J., Leitch A., Hayward B.E., Garner A., Parmar R., Griffith E., et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 38 (2006) 910-916
60. Stephenson J.B. Aicardi-Goutieres syndrome (AGS). Eur J Paediatr Neurol 12 (2008) 355-358
61. Orcesi S., Pessagno A., Biancheri R., La Piana R., Mascaretti M., Rossi A., et al. Aicardi-Goutieres syndrome presenting atypically as a sub-acute leukoencephalopathy. Eur J Paediatr Neurol 12 (2008) 408-411
62. Olivier M., Lenard H.G., Aksu F., and Gartner J. A new leukoencephalopathy with bilateral anterior temporal lobe cysts. Neuropediatrics 29 (1998) 225-228
63. Battini R., Bianchi M.C., Tosetti M., Guzzetta A., and Cioni G. Leukoencephalopathy with bilateral anterior temporal lobe cysts: a further case of this new entity. J Child Neurol 17 (2002) 773-776
64. Del Toro M., Arranz J.A., Macaya A., Riudor E., Raspall M., Moreno A., et al. Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension. Ann Neurol 60 (2006) 148-152
65. Naidu S., Bibat G., Lin D., Burger P., Barker P., Rosemberg S., et al. Progressive cavitating leukoencephalopathy: a novel childhood disease. Ann Neurol 58 (2005) 929-938
66. Labrune P., Lacroix C., Goutieres F., de Laveaucoupet J., Chevalier P., Zerah M., et al. Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: a new progressive disorder due to diffuse cerebral microangiopathy. Neurology 46 (1996) 1297-1301
67. Briggs T.A., Abdel-Salam G.M., Balicki M., Baxter P., Bertini E., Bishop N., et al. Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am J Med Genet A 146A (2008) 182-190
68. van der Knaap M.S., van der Voorn P., Barkhof F., Van Coster R., Krageloh-Mann I., Feigenbaum A., et al. A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol 53 (2003) 252-258
69. Serkov S.V., Pronin I.N., Bykova O.V., Maslova O.I., Arutyunov N.V., Muravina T.I., et al. Five patients with a recently described novel leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate. Neuropediatrics 35 (2004) 1-5
70. Scheper G.C., van der Klok T., van Andel R.J., van Berkel C.G., Sissler M., Smet J., et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39 (2007) 534-539
71. Uluc K., Baskan O., Yildirim K.A., Ozsahin S., Koseoglu M., Isak B., et al. Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. J Neurol Sci 273 (2008) 118-122
72. Gripp K.W., Zimmerman R.A., Wang Z.J., Rorke L.B., Duhaime A.C., Schut L., et al. Imaging studies in a unique familial dysmyelinating disorder. AJNR Am J Neuroradiol 19 (1998) 1368-1372
73. Madry H., Prudlo J., Grgic A., and Freyschmidt J. Nasu-Hakola disease (PLOSL): report of five cases and review of the literature. Clin Orthop Relat Res 454 (2007) 262-269
74. Neubauer B.A., Stefanova I., Hubner C.A., Neumaier-Probst E., Bohl J., Oppermann H.C., et al. A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27. Neurology 67 (2006) 587-591
75. Brockmann K., Pouwels P.J., Dechent P., Flanigan K.M., Frahm J., and Hanefeld F. Cerebral proton magnetic resonance spectroscopy of a patient with giant axonal neuropathy. Brain Dev 25 (2003) 45-50
76. Treiber-Held S., Budjarjo-Welim H., Reimann D., Richter J., Kretzschmar H.A., and Hanefeld F. Giant axonal neuropathy: a generalized disorder of intermediate filaments with longitudinal grooves in the hair. Neuropediatrics 25 (1994) 89-93
77. Yoon H.K., Sargent M.A., Prendiville J.S., and Poskitt K.J. Cerebellar and cerebral atrophy in trichothiodystrophy. Pediatr Radiol 35 (2005) 1019-1023
78. Willemsen M.A., Van Der Graaf M., Van Der Knaap M.S., Heerschap A., Van Domburg P.H., Gabreels F.J., et al. MR imaging and proton MR spectroscopic studies in Sjogren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 25 (2004) 649-657
79. Rizzo W.B., Craft D.A., Somer T., Carney G., Trafrova J., and Simon M. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjogren-Larsson syndrome. J Lipid Res 49 (2008) 410-419
80. Nakayama M., Tavora D.G., Alvim T.C., Araujo A.C., and Gama R.L. MRI and 1H-MRS findings of three patients with Sjogren-Larsson syndrome. Arq Neuropsiquiatr 64 (2006) 398-401
81. Ptacek L.J., Fu Y.H., and Koeppen A. The dominant form of vanishing white matter-like leukoencephalopathy represents autosomal dominant leukodystrophy. Ann Neurol 59 (2006) 434
82. Leuzzi V., Rinna A., Gallucci M., Di Capua M., Dionisi-Vici C., Longo D., et al. Ataxia, deafness, leukodystrophy: inherited disorder of the white matter in three related patients. Neurology 54 (2000) 2325-2328
83. Van Gerpen J.A., Wider C., Broderick D.F., Dickson D.W., Brown L.A., and Wszolek Z.K. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 71 (2008) 925-929
84. Lamer S., Carlier R.Y., Pinard J.M., Mompoint D., Bagard C., Burdairon E., et al. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology 206 (1998) 811-816
85. Vondracek P., Hermanova M., Vodickova K., Fajkusova L., Blakely E.L., He L., et al. An unusual case of congenital muscular dystrophy with normal serum CK level, external ophtalmoplegia, and white matter changes on brain MRI. Eur J Paediatr Neurol 11 (2007) 381-384
86. Lerman-Sagie T., Leshinsky-Silver E., Watemberg N., Luckman Y., and Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab 84 (2005) 127-136
87. Zafeiriou D.I., Rodenburg J.T., Scheffer H., van den Heuvel L.P., Pouwels P.J.W., Ververi A., et al. MR spectroscopy and serial magnetic resonance imaging in a patient with mitochondrial cystic leukoencephalopathy due to complex I deficiency and NDUFV1 mutations and mild clinical course. Neuropediatrics 39 (2008) 172-175
88. Grunewald S., Champion M.P., Leonard J.V., Schaper J., and Morris A.A. Biotinidase deficiency: a treatable leukoencephalopathy. Neuropediatrics 35 (2004) 211-216
89. Chatterjee A., Yapundich R., Palmer C.A., Marson D.C., and Mitchell G.W. Leukoencephalopathy associated with cobalamin deficiency. Neurology 46 (1996) 832-834
90. Horstmann M., Neumaier-Probst E., Lukacs Z., Steinfeld R., Ullrich K., and Kohlschutter A. Infantile cobalamin deficiency with cerebral lactate accumulation and sustained choline depletion. Neuropediatrics 34 (2003) 261-264
91. Longo D., Fariello G., Dionisi-Vici C., Cannata V., Boenzi S., Genovese E., et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics 36 (2005) 366-372
92. Klepper J., Engelbrecht V., Scheffer H., van der Knaap M.S., and Fiedler A. GLUT1 deficiency with delayed myelination responding to ketogenic diet. Pediatr Neurol 37 (2007) 130-133
93. de Lonlay P., Seta N., Barrot S., Chabrol B., Drouin V., Gabriel B.M., et al. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 38 (2001) 14-19
94. Thiel C., Schwarz M., Peng J., Grzmil M., Hasilik M., Braulke T., et al. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 278 (2003) 22498-22505
95. Carrilho I., Santos M., Guimaraes A., Teixeira J., Chorao R., Martins M., et al. Infantile neuroaxonal dystrophy: what's most important for the diagnosis?. Eur J Paediatr Neurol 12 (2008) 491-500
96. van den Boom R., Lesnik Oberstein S.A., Spilt A., Behloul F., Ferrari M.D., Haan J., et al. Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab 23 (2003) 599-604
97. Federico A., Bianchi S., and Dotti M.T. The spectrum of mutations for CADASIL diagnosis. Neurol Sci 26 (2005) 117-124
98. Adachi M., Kawanami T., Ohshima F., and Hosoya T. MR findings of cerebral white matter in Cockayne syndrome. Magn Reson Med Sci 5 (2006) 41-45
99. Rapin I., Weidenheim K., Lindenbaum Y., Rosenbaum P., Merchant S.N., Krishna S., et al. Cockayne syndrome in adults: review with clinical and pathologic study of a new case. J Child Neurol 21 (2006) 991-1006
100. Itoh M., Suzuki Y., Sugai K., Ozuka N., Ohsawa M., Otsuki T., et al. Progressive leukoencephalopathy associated with aluminum deposits in myelin sheath. J Child Neurol 23 (2008) 938-943